Real Diabetes Management Part 2: The Burning Need for Interoperability & Standards
{Note: this is second in a two-part series aimed not only at patients, but those in the Pharma industry as well.}
I was interviewed the other day for an upcoming story about Sanofi-Aventis’ new strategy to not just offer individual diabetes products, but become a “full diabetes management vendor.” They are not alone. Medtronic, Roche, Bayer, Abbott and others are among the big industry players talking about more of a “systems approach” to diabetes as…